Design, synthesis and evaluation of Novel Group II Metabotropic Glutamate Receptor Allosteric Modulators in rodent models of CNS disorders

被引：0

作者：

Cosford, N. D. P. ^{[1
]}

Dhanya, R. ^{[1
]}

Sidique, S. ^{[1
]}

Dahl, R. ^{[1
]}

D'Souza, M. S. ^{[2
]}

Semenova, S. ^{[2
]}

Der-Avakian, A. ^{[2
]}

Conn, P. J. ^{[3
]}

Sheffler, D. J. ^{[1
]}

Markou, A. ^{[2
]}

机构：

[1] Sanford Burnham Med Res Inst, La Jolla, CA USA

[2] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA

[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S-07-002

引用

页码：9 / 9

页数：1

共 50 条

[1] Design and synthesis of novel metabotropic glutamate receptor allosteric modulators
Stankiewicz, Anna
Bugno, Ryszard
Branski, Piotr
Bojarski, Andrzej J.
[J]. PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 473 - 474
[2] Design and synthesis of novel metabotropic glutamate receptor allosteric modulators
Anna Stankiewicz
Ryszard Bugno
Piotr Brański
Andrzej J. Bojarski
[J]. Pharmacological Reports, 2012, 64 : 473 - 474
[3] DESIGN, SYNTHESIS AND CHARACTERIZATION OF SMALL MOLECULE GROUP II METABOTROPIC GLUTAMATE RECEPTOR ALLOSTERIC MODULATORS
Cosford, N. D. P.
[J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 129A - 129A
[4] Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics
Walker, Adam G.
Conn, P. Jeffrey
[J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 20 : 40 - 45
[5] Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators
Sheffler, Douglas J.
Pinkerton, Anthony B.
Dahl, Russell
Markou, Athina
Cosford, Nicholas D. P.
[J]. ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08): : 382 - 393
[6] Design, synthesis, and preclinical characterization of small molecule group II metabotropic glutamate receptor positive allosteric modulators
Cosford, Nicholas
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[7] Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
Fell, Matthew J.
McKinzie, David L.
Monn, James A.
Svensson, Kjell A.
[J]. NEUROPHARMACOLOGY, 2012, 62 (03) : 1473 - 1483
[8] Design, Synthesis, and Evaluation of Novel Metabotropic Glutamate Subtype-2 (mGlu2) Receptor Positive Allosteric Modulators (PAMs) in Rodent Models of Drug Dependence
Cosford, N.
Dhanya, R.
Sidique, S.
Sheffler, D.
Nickols, H.
Herath, A.
Yang, L.
Dahl, R.
Ardecky, R.
Semenova, S.
Conn, P. J.
Markou, A.
[J]. CURRENT NEUROPHARMACOLOGY, 2011, 9 : 12 - 12
[9] Pharmacology of Metabotropic Glutamate Receptor Allosteric Modulators: Structural Basis and Therapeutic Potential for CNS Disorders
Gregory, Karen J.
Noetzel, Meredith J.
Niswender, Colleen M.
[J]. OLIGOMERIZATION AND ALLOSTERIC MODULATION IN G-PROTEIN COUPLED RECEPTORS, 2013, 115 : 61 - 121
[10] Progress Towards Novel Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators for CNS disorders
Celanire, S.
[J]. CURRENT NEUROPHARMACOLOGY, 2014, 12 : 9 - 9

← 1 2 3 4 5 →